New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

FMEDvsWDNAETF Comparison

ETF 1
FMED

Fidelity Disruptive Medicine ETF

This fund is part of
Multiple Trends
-6.5%
VS
ETF 2
WDNA

WisdomTree BioRevolution Fund

This fund is part of
BioTech & Genomics
-1.76%

Fidelity Disruptive Medicine ETF (FMED) belongs to the Multiple Trends segment. WisdomTree BioRevolution Fund (WDNA) is part of the BioTech & Genomics segment. FMED's top 1 sector exposures are Healthcare. In contrast, WDNA's top sector exposures are Healthcare, Non-Energy Materials and Consumer Non-Cyclicals. FMED is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.45% for WDNA. FMED is up 14.76% year-to-date (YTD) with -$20M in YTD flows. WDNA performs better with 33.87% YTD performance, and +$1M in YTD flows. Run a side-by-side ETF comparison of FMED and WDNA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FMED vs WDNA performance and flow charts

Performance

-8.0-6.0-4.0-2.00.02.04.0%Oct 5Oct 12Oct 19Oct 26Nov 2

Cumulative Flows

-3,000,000-2,000,000-1,000,0000Oct 5Oct 12Oct 19Oct 26Nov 2

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/05/2026
1M3MYTD1Y3Y5Y
Perf.
FMED
WDNA
-4.35%-6.50%
+7.81%+12.01%
+14.76%+33.87%
+19.85%+45.21%
+48.91%+65.56%
n/a-7.11%
Flows
FMED
WDNA
-$3M+$239K
-$3M+$2M
-$20M+$1M
-$18M+$1M
-$15M+$1M
-+$3M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FMED
WDNA
+31.58%+40.83%
+24.11%+28.98%
+20.23%+26.99%
n/a+26.31%
Max drawdown
FMED
WDNA
-7.63%-8.16%
-17.78%-11.90%
-19.20%-36.45%
n/a-55.67%
Max drawdown duration
FMED
WDNA
69d7d
212d147d
267d595d
n/a1814d
Trading data

Create an account to view trading data

Join for free
FMED
WDNA
Last sale
11/6/2026 at 2:30 PM
$23.09
Previous close
11/04/2026
$22.77
Consolidated volume
11/04/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of November 7, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

FMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
FMED
WDNA
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/6/2026 at 2:30 PM
Live
Closed
FMED
WDNA
Last price
–
$23.09
1D performance
–
+1.41%
AuM$47.38 M$4.75 M
E/R0.5%0.45%
Characteristics
FMED
WDNA
Management strategyActivePassive
ProviderFidelityWisdomTree
Benchmark-WisdomTree BioRevolution ESG Screened Index
N° of holdings7179
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJune 12, 2023June 3, 2021
ESGNoYes
Advertisement
Exposure

Countries

FMED
USA
84.97%
Other
15.03%
WDNA
USA
86.29%
Other
13.71%

Sectors

FMED
Healthcare
99.49%
Other
0.51%
WDNA
Healthcare
90.77%
Other
9.23%

Diversification

FMED

Total weight of top 15 holdings out of 15

47.18%
WDNA

Total weight of top 15 holdings out of 15

50.08%

Top 15 holdings

Data as of September 30, 2026
FMED
10X Genomics, Inc.
5.82%
Natera, Inc.
4.47%
Thermo Fisher Scientific, Inc.
4.19%
Danaher Corp.
3.92%
Illumina, Inc.
3.56%
argenx SE
2.96%
Lifestance Health Group, Inc.
2.87%
Revolution Medicines, Inc.
2.86%
Sartorius Stedim Biotech SA
2.72%
Moderna, Inc.
2.62%
Alnylam Pharmaceuticals, Inc.
2.48%
HeartFlow, Inc.
2.39%
Intuitive Surgical, Inc.
2.20%
Cogent Biosciences, Inc.
2.13%
Caris Life Sciences, Inc.
1.99%
WDNA
Moderna, Inc.
10.44%
Twist Bioscience Corp.
9.31%
10X Genomics, Inc.
3.68%
Eli Lilly & Co.
3.47%
Natera, Inc.
3.09%
Tempus AI, Inc.
2.82%
Johnson & Johnson
2.69%
Iovance Biotherapeutics, Inc.
2.32%
Immunome, Inc.
2.02%
United Therapeutics Corp.
1.86%
Darling Ingredients, Inc.
1.85%
Thermo Fisher Scientific, Inc.
1.75%
Revolution Medicines, Inc.
1.60%
Corteva, Inc.
1.58%
CRISPR Therapeutics AG
1.58%
Frequently asked questions about FMED and WDNA

How have the FMED and WDNA ETFs performed in 2026?

As of November 5, 2026, FMED is up 14.76% year-to-date (YTD), while WDNA has returned 33.87%. That puts WDNA better performer ahead so far this year.

Which ETF is attracting more investor money: FMED or WDNA?

Year-to-date, the FMED ETF saw -$20M in flows, compared to +$1M for WDNA.

Which ETF is more volatile: FMED or WDNA?

Over the past year, FMED had a volatility of 24.11%, while WDNA experienced 28.98%.

Which ETF is bigger: FMED or WDNA?

As of November 5, 2026, FMED holds $47.38 M in assets under management (AUM), while WDNA manages $4.75 M.

What sectors do the FMED and WDNA ETFs invest in?

FMED leans toward sectors like Healthcare. Meanwhile, WDNA focuses on Healthcare.

What are the top holdings of the FMED ETF and WDNA ETF?

FMED top holdings include 10X Genomics, Inc., Natera, Inc. and Thermo Fisher Scientific, Inc.. WDNA holds in its top three: Moderna, Inc., Twist Bioscience Corp. and 10X Genomics, Inc..

Which ETF is more diversified: FMED or WDNA?

FMED holds 71 securities with 47.18% of its assets in the top 15. WDNA has 79 securities and a top 15 weight of 50.08%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026